These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.
and disease activity in the year before versus after CAR T-cell therapy using paired McNemar's tests. ASTCT=American Society for Transplantation and Cellular Therapy. ICANS=immune effector ...
Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...
Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...
Masked T Cell Engager Programs T cell engagers are designed to redirect immune effector cells against cancer cells by simultaneously binding to a specific tumor-associated antigen expressed on the ...
Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
Using both mouse experimental colitis models and IBD patient biopsies, here the authors implicate increased tissue factor activity on colitogenic T cells as a potential link. Although effector ...
Exploratory study of TAS-102 combined with intermittent administration of fruquintinib in the treatment of third-line metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Unfortunately, there were many anime fans who weren’t thrilled with the design of “Cell Max,” the latest and ultimate creation of the Red Ribbon Army. In a surprising turn of events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results